COOPER DEVELOPMENT ltBUGS RESTATES RESULTS Cooper Development revised results year ended October 31 loss 617 mln dlrs 233 dlrs share previouslyreported loss 121 mln dlrs 46 cts share restatement made change method accounting combination companycontrolled concerns resulted 535 mln dlr charge Cooper Development said August Cooper Development combined Cooper Biomedical unit Cooper Laboratories subsidiary Technicon Instruments Corp company acquired Revlon ltREV Cooper spokesman said spokesman transaction accounted acquisition Securities Exchange Commission issue accounting method accounted reorganization entities common control treatment requires costs transaction expanded capitalized intangible asset company said that charged required expensing previously accrued liabilities company experience resulting material change cash flow